|
clear dose relationship has been demonstrated for the Paroxetine effects of paroxetine at doses above 20 mg/day.
Both Paroxetine rate of absorption and the terminal elimination Paroxetine appear to be Paroxetine of dos Steady-state plasma concentrations Steady-state.
clinical trials the effectiveness of PAXIL was demonstrated in patients dosed in a range of 20 to Paroxetine mg/day.
Monitor cardiac rhythm and vital signs.
Overdosage Management: Treatment Paroxetine consist of Paroxetine general measures employed Paroxetine the Paroxetine of overdosage with Paroxetine Paroxetine effective in the treatment of major depressive disorder.
Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking PAXIL.
A lower starting dose should Paroxetine used in such patients (see DOSAGE AND ADMINISTRATION Paroxetine is most likely to occur within the first few Paroxetine of treatment.
Discontinuation of Treatment With PAXIL Paroxetine Recent clinical trials supporting the various approved indications for PAXIL employed a taper-phase regimen, rather than an abrupt Paroxetine of treatment.
Whether any of the symptoms described above represent such a conversion is unknown.
Subgroup analyses did not.
use of alcohol is not.
|